AIM ImmunoTech Management
Management criteria checks 3/4
AIM ImmunoTech's El consejero delegado es Thomas Equels , nombrado en Aug 2015, tiene un mandato de 8.33 años. la remuneración anual total es $1.35M , compuesta por 62.9% salario y 37.1% primas, incluidas acciones y opciones de la empresa. posee directamente 1.31% de las acciones de la empresa, por valor de $323.62K . La antigüedad media del equipo directivo y del consejo de administración es de 8.3 años y 7.3 años respectivamente.
Key information
Thomas Equels
Chief executive officer
US$1.4m
Total compensation
CEO salary percentage | 62.9% |
CEO tenure | 8.7yrs |
CEO ownership | 1.5% |
Management average tenure | 8.7yrs |
Board average tenure | 7.7yrs |
Recent management updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | n/a | n/a | -US$29m |
Sep 30 2023 | n/a | n/a | -US$21m |
Jun 30 2023 | n/a | n/a | -US$19m |
Mar 31 2023 | n/a | n/a | -US$19m |
Dec 31 2022 | US$1m | US$850k | -US$19m |
Sep 30 2022 | n/a | n/a | -US$21m |
Jun 30 2022 | n/a | n/a | -US$18m |
Mar 31 2022 | n/a | n/a | -US$19m |
Dec 31 2021 | US$2m | US$850k | -US$19m |
Sep 30 2021 | n/a | n/a | -US$17m |
Jun 30 2021 | n/a | n/a | -US$17m |
Mar 31 2021 | n/a | n/a | -US$14m |
Dec 31 2020 | US$3m | US$807k | -US$14m |
Sep 30 2020 | n/a | n/a | -US$12m |
Jun 30 2020 | n/a | n/a | -US$11m |
Mar 31 2020 | n/a | n/a | -US$10m |
Dec 31 2019 | US$890k | US$703k | -US$9m |
Sep 30 2019 | n/a | n/a | -US$10m |
Jun 30 2019 | n/a | n/a | -US$10m |
Mar 31 2019 | n/a | n/a | -US$10m |
Dec 31 2018 | US$1m | US$751k | -US$10m |
Sep 30 2018 | n/a | n/a | -US$10m |
Jun 30 2018 | n/a | n/a | -US$8m |
Mar 31 2018 | n/a | n/a | -US$8m |
Dec 31 2017 | US$987k | US$713k | -US$8m |
Compensación vs. Mercado: Thomas($USD1.35M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD667.91K).
Compensación vs. Ingresos: La compensación de Thomas ha sido consistente con los resultados de la empresa en el último año.
CEO
Thomas Equels (70 yo)
8.7yrs
Tenure
US$1,352,028
Compensation
Mr. Thomas K. Equels, Esq. M.S., J.D. serves as Director at BioFlorida Inc since August 2021. He serves as the Chief Executive Officer of AIM ImmunoTech Inc. (formerly known as Hemispherx Biopharma, Inc.)...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Executive Vice Chairman | 8.7yrs | US$1.35m | 1.47% $ 341.2k | |
Chief Financial Officer | 2yrs | US$60.98k | no data | |
COO, Executive Director of Governmental Relations | 7.5yrs | US$699.30k | 0.37% $ 86.5k | |
Director of Administration & Human Resources and Deputy Investor Relations Coordinator | 11.3yrs | no data | no data | |
Chief Manufacturing Officer & Deputy Chief Scientific Officer | 31.3yrs | US$171.37k | no data | |
Scientific Officer | 1.3yrs | no data | no data | |
Vice President of QC & Manufacturing | 14yrs | no data | no data |
8.7yrs
Average Tenure
70yo
Average Age
Equipo directivo experimentado: AIMEl equipo directivo de la empresa es veterano y experimentado (8.3 años de antigüedad media).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Executive Vice Chairman | 15.4yrs | US$1.35m | 1.47% $ 341.2k | |
Member of Scientific Advisory Board | no data | no data | no data | |
Independent Chairman of the Board & Member of Scientific Advisory Board | 25.8yrs | US$233.17k | 0.16% $ 36.4k | |
Member of Scientific Advisory Board | no data | no data | no data | |
Independent Director | 1.1yrs | no data | 0.079% $ 18.3k | |
Independent Director | 7.7yrs | US$233.17k | 0.49% $ 114.2k | |
Chairman of Scientific Advisory Board | less than a year | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data |
7.7yrs
Average Tenure
69yo
Average Age
Junta con experiencia: La junta directiva de AIM se considera experimentada (7.3 años de antigüedad promedio).